Adaptimmune Therapeutics plc earnings per share and revenue

ADAP earnings per share for the last quarter are -0.05 USD whereas the estimation was -0.03 USD which accounts for -68.45% surprise. Company revenue for the same period amounts to 3.20 M USD despite the estimated figure of 7.84 M USD. Estimated earnings per share for the next quarter are -0.11 USD, and revenue is expected to reach 7.13 M USD. Also watch annual changes over time to get a bigger picture of ADAP earnings per share and revenue dynamics.